Fort Sheridan Advisors LLC Crispr Therapeutics Ag Transaction History

Fort Sheridan Advisors LLC

  • $613 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$110.2 - $156.64 $201,555 - $286,494
-1,829 Closed
0 $0
Q2 2021

Aug 17, 2021
BUY
$100.84 - $161.89 $10,084 - $16,188
100 Added 5.78%
1,829 $296,000
Q1 2021

May 17, 2021
BUY
$110.72 - $210.04 $30,115 - $57,130
272 Added 18.67%
1,729 $211,000
Q4 2020

Feb 16, 2021
BUY
$79.67 - $173.23 $116,079 - $252,396
1,457 New
1,457 $223,000

Others Institutions Holding CRSP

# of Institutions
523
Shares Held
58M
Call Options Held
1.73M
Put Options Held
1.84M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.67B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Fort Sheridan Advisors LLC Portfolio

Follow Fort Sheridan Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Sheridan Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Sheridan Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email